NOVA AUSTRAL S.A. financials
NOVA AUSTRAL S.A.
213800FU5HJ5AXKACP98 | Line item | 2021 | 2020 |
|---|---|---|
| Income statement | ||
| Revenue | $89.9M | $149.5M |
| Cost of sales | $100.9M | $149.6M |
| Gross profit | -$11.0M | -$52.0K |
| Distribution costs | $9.7M | $17.4M |
| Administrative expenses | $8.1M | $13.9M |
| Finance costs | $45.5M | $41.0M |
| Profit before tax | -$43.1M | -$84.2M |
| Income tax expense | $7.3M | -$3.1M |
| Profit for the year | -$50.3M | -$81.0M |
| — attributable to owners | -$56.8M | -$77.9M |
| — attributable to NCI | $6.5M | -$3.2M |
| Total comprehensive income | -$50.6M | -$81.0M |
| Cash flow statement | ||
| Net cash from operating activities | -$16.5M | $8.8M |
| Net cash from investing activities | $2.1M | -$2.0M |
| Purchase of PP&E (capex) | $3.0M | $4.5M |
| Purchase of intangibles | $0 | $1.4M |
| Net cash from financing activities | $12.1M | -$18.2M |
| Proceeds from borrowings | $21.3M | $12.1M |
| Repayments of borrowings | $3.8M | $3.8M |
| Net change in cash | -$2.3M | -$11.5M |
| Balance sheet | ||
| Total assets | $372.7M | $363.8M |
| Non-current assets | $235.5M | $240.9M |
| Property, plant & equipment | $99.3M | $106.7M |
| Current assets | $137.3M | $122.9M |
| Inventories | $14.1M | $20.5M |
| Trade & other receivables | $4.9M | $14.4M |
| Cash & equivalents | $3.2M | $4.8M |
| Total equity | -$131.0M | -$77.0M |
| — attributable to owners | -$135.0M | -$78.0M |
| Non-controlling interests | $4.1M | $1.0M |
| Non-current liabilities | $370.8M | $331.3M |
| Current liabilities | $132.9M | $109.5M |
| Trade & other payables | $45.2M | $52.3M |
| Deferred tax liabilities | $5.6M | $0 |
| Derived metrics | ||
| Free cash flow | -$19.5M | $4.2M |
| Net margin | -55.9% | -54.2% |
| Return on equity | 38.4% | 105.3% |
| Cash conversion ratio | 0.33× | -0.11× |
| Capex coverage | -5.56× | 1.93× |
| Other reported items | ||
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | $2.0M | $1.4M |
| Cash Receipts From Repayment of Advances and Loans Made To Related Parties | $6.8M | $5.3M |
| Changes In Equity | -$54.0M | -$80.7M |
| Comprehensive Income Attributable To Noncontrolling Interests | $6.5M | -$3.2M |
| Comprehensive Income Attributable To Owners of Parent | -$57.1M | -$77.9M |
| Current Biological Assets | $88.1M | $51.4M |
| Current Provisions For Employee Benefits | $1.4M | $1.7M |
| Current Tax Assets Current | $16.6M | $24.3M |
| Deferred Tax Assets | $2.4M | $3.7M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | $706.0K | $57.0K |
| Equity and Liabilities | $372.7M | $363.8M |
| Finance Income | $8.6M | $9.2M |
| Gains Losses On Change In Fair Value Estimates of Biological Assets For Current Period | $21.1M | -$72.0K |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | $474.0K | $89.0K |
| Gains Losses On Fair Value Adjustment Biological Assets | $725.0K | -$19.1M |
| Income Taxes Paid Refund Classified As Operating Activities | -$10.4M | -$8.1M |
| Increase Decrease In Cash and Cash Equivalents | -$1.6M | -$11.4M |
| Increase Decrease Through Transfers and Other Changes Equity | -$3.4M | $380.0K |
| Intangible Assets Other Than Goodwill | $9.8M | $8.5M |
| Interest Paid Classified As Financing Activities | $5.3M | $17.0M |
| Issued Capital | $1.0M | $1.0M |
| Liabilities | $503.7M | $440.8M |
| Noncurrent Payables | $757.0K | $902.0K |
| Noncurrent Receivables | $472.0K | $433.0K |
| Noncurrent Receivables Due From Related Parties | $123.4M | $121.6M |
| Other Cash Receipts From Operating Activities | $13.4M | $15.2M |
| Other Comprehensive Income | -$277.0K | -$9.0K |
| Other Current Financial Liabilities | $74.0M | $51.7M |
| Other Current Nonfinancial Assets | $10.3M | $7.5M |
| Other Current Nonfinancial Liabilities | $1.9M | $1.4M |
| Other Expense By Function | $7.7M | $16.3M |
| Other Gains Losses | $8.0M | $14.4M |
| Other Inflows Outflows of Cash Classified As Financing Activities | -$49.0K | -$1.4M |
| Other Inflows Outflows of Cash Classified As Operating Activities | -$289.0K | -$1.0M |
| Other Noncurrent Financial Liabilities | $364.4M | $330.4M |
| Payments For Premiums and Claims Annuities and Other Policy Benefits | $1.2M | $2.5M |
| Payments To and On Behalf of Employees | $19.6M | $22.6M |
| Payments To Suppliers For Goods and Services | $111.0M | $143.7M |
| Proceeds From Issuing Shares | $0 | $0 |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | $290.0K | $0 |
| Receipts From Premiums and Claims Annuities and Other Policy Benefits | $2.9M | $1.1M |
| Receipts From Sales of Goods and Rendering of Services | $88.9M | $154.1M |
| Repayments of Current Borrowings | $0 | $8.2M |
| Retained Earnings | -$136.0M | -$78.9M |
| Trade and Other Current Payables To Related Parties | $10.5M | $2.3M |
| Trade and Other Current Receivables Due From Related Parties | $85.0K | $79.0K |
Every line item above is a fact tagged in NOVA AUSTRAL S.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (USD), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.